Genaxy Scientific Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-06-2024
- Paid Up Capital ₹ 0.60 M
as on 15-06-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 M
as on 15-06-2024
- Revenue -54.31%
(FY 2023)
- Profit -80.56%
(FY 2023)
- Ebitda -84.00%
(FY 2023)
- Net Worth 6.09%
(FY 2023)
- Total Assets 3.79%
(FY 2023)
About Genaxy Scientific
The Corporate was formerly known as Axygen Scientific Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.60 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Gupta, Navneet Trehan, and Saurabh Gupta serve as directors at the Company.
- CIN/LLPIN
U33125HP1998PTC022097
- Company No.
022097
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Himachal Pradesh, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genaxy Scientific Private Limited offer?
Genaxy Scientific Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Plastic & Glass Labware, Laboratory Plasticware, Mirrors and Glassware, Glassware, Indoor Lights & Lighting Accessories, Lighting Accessories, Hematology Analyzers.
Who are the key members and board of directors at Genaxy Scientific?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Saurabh Gupta | Director | 08-Mar-2012 | Current |
Mukesh Gupta | Director | 29-Dec-1998 | Current |
Navneet Trehan | Director | 03-Dec-2003 | Current |
Financial Performance of Genaxy Scientific.
Genaxy Scientific Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 54.31% decrease. The company also saw a substantial fall in profitability, with a 80.56% decrease in profit. The company's net worth moved up by a moderate rise of 6.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Genaxy Scientific?
In 2023, Genaxy Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Future Bio-Science Private LimitedActive 19 years 9 months
Mukesh Gupta and Navneet Trehan are mutual person
- Genaxy Bioinnovations Private LimitedActive 10 months
Mukesh Gupta, Navneet Trehan and 1 more are mutual person
- Bio Genex Surgicals India Pvt LtdActive 30 years 3 months
Mukesh Gupta and Saurabh Gupta are mutual person
- Trehan's Appointment With Success Private LimitedActive 13 years 7 months
Navneet Trehan is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 13 Oct 1999 | ₹1.00 M | Satisfied |
How Many Employees Work at Genaxy Scientific?
Genaxy Scientific has a workforce of 54 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genaxy Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genaxy Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.